Diffusion Weighted Magnetic Resonance Imaging of the Breast: Protocol Optimization, Interpretation, and Clinical Applications

Magnetic Resonance Imaging Clinics of North America

Volumn 21, Issue 3, 2013, Pages 601-624

  Partridge, Savannah C ^a   McDonald, Elizabeth S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Apparent diffusion coefficient; B value; Breast cancer; Breast MR imaging; Diffusion weighted imaging; Neoadjuvant chemotherapy; Oncologic imaging

Indexed keywords

BENIGN TUMOR; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; DATA ANALYSIS; DIFFUSION WEIGHTED IMAGING; DRUG RESPONSE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; REVIEW;

EID: 84881367367     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2013.04.007     Document Type: Review

References (104)

1. Matoba M., Tonami H., Kondou T., et al. Lung carcinoma: diffusion-weighted MR imaging-preliminary evaluation with apparent diffusion coefficient. Radiology 2007, 243(2):570-577.
2. 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008, 246(2):480-488.
3. Ohno Y., Koyama H., Onishi Y., et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008, 248(2):643-654.
4. Parikh T., Drew S.J., Lee V.S., et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008, 246(3):812-822.
5. Zhang J., Tehrani Y.M., Wang L., et al. Renal masses: characterization with diffusion-weighted MR imaging-a preliminary experience. Radiology 2008, 247(2):458-464.
6. Englander S.A., Ulug A.M., Brem R., et al. Diffusion imaging of human breast. NMR Biomed 1997, 10(7):348-352.
7. Guo Y., Cai Y.Q., Cai Z.L., et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. JMagn Reson Imaging 2002, 16(2):172-178.
8. Hatakenaka M., Soeda H., Yabuuchi H., et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008, 7(1):23-29.
9. Kinoshita T., Yashiro N., Ihara N., et al. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. JComput Assist Tomogr 2002, 26(6):1042-1046.
10. Marini C., Iacconi C., Giannelli M., et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007, 17(10):2646-2655.
11. Rubesova E., Grell A.S., De Maertelaer V., et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. JMagn Reson Imaging 2006, 24(2):319-324.
12. Sinha S., Lucas-Quesada F.A., Sinha U., et al. Invivo diffusion-weighted MRI of the breast: potential for lesion characterization. JMagn Reson Imaging 2002, 15(6):693-704.
13. Wenkel E., Geppert C., Schulz-Wendtland R., et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 2007, 14(9):1077-1083.
14. Woodhams R., Matsunaga K., Kan S., et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005, 4(1):35-42.
15. Park M.J., Cha E.S., Kang B.J., et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007, 8(5):390-396.
16. Partridge S.C., DeMartini W.B., Kurland B.F., et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009, 193(6):1716-1722.
17. Partridge S.C., Demartini W.B., Kurland B.F., et al. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. JMagn Reson Imaging 2010, 31(3):562-570.
18. Yabuuchi H., Matsuo Y., Okafuji T., et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. JMagn Reson Imaging 2008, 28(5):1157-1165.
19. Yoshikawa M.I., Ohsumi S., Sugata S., et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008, 26(4):222-226.
20. Fangberget A., Nilsen L.B., Hole K.H., et al. Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 2011, 21(6):1188-1199.
21. Sharma U., Danishad K.K., Seenu V., et al. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22(1):104-113.
22. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. JNatl Cancer Inst 2000, 92(24):2029-2036.
23. Iacconi C., Giannelli M., Marini C., et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2010, 20(2):303-308.
24. Li X.R., Cheng L.Q., Liu M., et al. DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol 2012, 29(2):425-431.
25. Park S.H., Moon W.K., Cho N., et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010, 257(1):56-63.
26. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006, 24(7):843-847.
27. Theilmann R.J., Borders R., Trouard T.P., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004, 6(6):831-837.
28. Einstein A. Investigations on the theory of the Brownian movement 1956, Dover Publications, Mineola (NY).
29. Le Bihan D., Breton E., Lallemand D., et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988, 168(2):497-505.
30. Stejskal E.O., Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. JChem Phys 1965, 42:288-292.
31. Le Bihan D., Breton E., Lallemand D., et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161(2):401-407.
32. Hagmann P., Jonasson L., Maeder P., et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006, 26(Suppl 1):S205-S223.
33. Bogner W., Gruber S., Pinker K., et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?. Radiology 2009, 253(2):341-351.
34. Tsushima Y., Takahashi-Taketomi A., Endo K. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. JMagn Reson Imaging 2009, 30(2):249-255.
35. Kuroki Y., Nasu K. Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 2008, 15(3):212-217.
36. Woodhams R., Ramadan S., Stanwell P., et al. Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics 2011, 31(4):1059-1084.
37. Pereira F.P., Martins G., Figueiredo E., et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol 2009, 193(4):1030-1035.
38. Peters N.H., Vincken K.L., van den Bosch M.A., et al. Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions:the influence of the choice of b-values. JMagn Reson Imaging 2010, 31(5):1100-1105.
39. Jin G., An N., Jacobs M.A., et al. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010, 17(4):456-463.
40. Pereira F.P., Martins G., Carvalhaes de Oliveira Rde V. Diffusion magnetic resonance imaging of the breast. Magn Reson Imaging Clin N Am 2011, 19(1):95-110.
41. Jones D.K., Horsfield M.A., Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999, 42(3):515-525.
42. Partridge S.C., Singer L., Sun R., et al. Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. Magn Reson Imaging 2011, 29(9):1215-1221.
43. Baron P., Dorrius M.D., Kappert P., et al. Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient. NMR Biomed 2010, 23(4):399-405.
44. Baltzer P.A., Renz D.M., Herrmann K.H., et al. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009, 19(7):1612-1620.
45. Le Bihan D., Poupon C., Amadon A., et al. Artifacts and pitfalls in diffusion MRI. JMagn Reson Imaging 2006, 24(3):478-488.
46. Singer L., Wilmes L.J., Saritas E.U., et al. High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol 2012, 19(5):526-534.
47. Bammer R., Keeling S.L., Augustin M., et al. Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001, 46(3):548-554.
48. Kuhl C.K., Gieseke J., von Falkenhausen M., et al. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. Radiology 2005, 234(2):517-526.
49. Chen G., Jespersen S.N., Pedersen M., et al. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005, 23(5):685-689.
50. Fitzek C., Mentzel H.J., Fitzek S., et al. Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA. Neuroradiology 2003, 45(9):592-597.
51. Ogura A., Hayakawa K., Miyati T., et al. The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol 2008, 15(7):867-872.
52. Wang C.L., Chea Y.W., Boll D.T., et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Eur J Radiol 2011, 80(2):e1-e7.
53. Liu X., Zhou L., Peng W., et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging. Acta Radiol 2011, 52(5):575-580.
54. Firat A.K., Sanli B., Karakas H.M., et al. The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging. Neuroradiology 2006, 48(7):465-470.
55. Naganawa S., Sato C., Nakamura T., et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. JMagn Reson Imaging 2005, 21(6):836-840.
56. Yuen S., Yamada K., Goto M., et al. Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. JMagn Reson Imaging 2009, 29(5):1080-1084.
57. Nguyen VT, Olson ML, Rahbar H, etal. Effects of intravascular contrast agents on breast apparent diffusion coefficient measures. Paper presented at: American Roentgen Ray Society (ARRS) Annual Meeting. Washington, DC, April 14-19, 2013.
58. El Khouli R.H., Jacobs M.A., Mezban S.D., et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 2010, 256(1):64-73.
59. Yoshikawa M.I., Ohsumi S., Sugata S., et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 2007, 25(5):218-223.
60. Clendenen T.V., Kim S., Moy L., et al. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 2013, 31(1):1-9.
61. O'Flynn E.A., Morgan V.A., Giles S.L., et al. Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status. Eur Radiol 2012, 22(7):1512-1518.
62. Partridge S.C., McKinnon G.C., Henry R.G., et al. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. JMagn Reson Imaging 2001, 14(4):433-438.
63. Schopp J, Rahbar H, DeMartini WB, etal. Diffusion-weighted MRI: influence of patient characteristics on apparent diffusion coefficient values of normal breast parenchyma measured at 3 tesla. Paper presented at: American Roentgen Ray Society (ARRS) Annual Meeting. Washington, DC, April 14-19, 2013.
64. Woodhams R., Matsunaga K., Iwabuchi K., et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. JComput Assist Tomogr 2005, 29(5):644-649.
65. Partridge S.C., Mullins C.D., Kurland B.F., et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010, 194(6):1664-1673.
66. Lyng H., Haraldseth O., Rofstad E.K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000, 43(6):828-836.
67. Sugahara T., Korogi Y., Kochi M., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. JMagn Reson Imaging 1999, 9(1):53-60.
68. Chen X., Li W.L., Zhang Y.L., et al. Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer 2010, 10:693.
69. Rahbar H., Partridge S.C., Eby P.R., et al. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 2011, 21(9):2011-2019.
70. Rahbar H., Partridge S.C., Demartini W.B., et al. Invivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology 2012, 263(2):374-382.
71. Iima M., Le Bihan D., Okumura R., et al. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study. Radiology 2011, 260(2):364-372.
72. Cheng L., Bai Y., Zhang J., et al. Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. Tumour Biol 2013, [Epub ahead of print].
73. Yabuuchi H., Matsuo Y., Kamitani T., et al. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Eur J Radiol 2010, 75(1):e126-e132.
74. Imamura T., Isomoto I., Sueyoshi E., et al. Diagnostic performance of ADC for non-mass-like breast lesions on MR imaging. Magn Reson Med Sci 2010, 9(4):217-225.
75. Woodhams R., Kakita S., Hata H., et al. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. AJR Am J Roentgenol 2009, 193(1):260-266.
76. Kul S., Cansu A., Alhan E., et al. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011, 196(1):210-217.
77. Parsian S., Rahbar H., Allison K.H., et al. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology 2012, 265(3):696-706.
78. Peters N.H., Borel Rinkes I.H., Zuithoff N.P., et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008, 246(1):116-124.
79. Partridge S.C., Rahbar H., Murthy R., et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011, 65(6):1759-1767.
80. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?. AJR Am J Roentgenol 2009, 193(3):840-849.
81. Costantini M., Belli P., Rinaldi P., et al. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol 2010, 65(12):1005-1012.
82. Jeh S.K., Kim S.H., Kim H.S., et al. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. JMagn Reson Imaging 2011, 33(1):102-109.
83. Martincich L., Deantoni V., Bertotto I., et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 2012, 22(7):1519-1528.
84. Razek A.A., Gaballa G., Denewer A., et al. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 2010, 23(6):619-623.
85. Youk J.H., Son E.J., Chung J., et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol 2012, 22(8):1724-1734.
86. Choi S.Y., Chang Y.W., Park H.J., et al. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 2012, 85(1016):e474-e479.
87. Kim S.H., Cha E.S., Kim H.S., et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. JMagn Reson Imaging 2009, 30(3):615-620.
88. Agarwal R., Brunelli S.M., Williams K., et al. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 2009, 24(3):856-863.
89. Kaewlai R., Abujudeh H. Nephrogenic systemic fibrosis. AJR Am J Roentgenol 2012, 199(1):W17-W23.
90. Kuroki-Suzuki S., Kuroki Y., Nasu K., et al. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007, 6(1):21-27.
91. Yabuuchi H., Matsuo Y., Sunami S., et al. Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 2011, 21(1):11-17.
92. Baltzer P.A., Benndorf M., Dietzel M., et al. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 2010, 20(5):1101-1110.
93. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006, 94(3):427-435.
94. Nilsen L., Fangberget A., Geier O., et al. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010, 49(3):354-360.
95. Woodhams R., Kakita S., Hata H., et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 2010, 254(2):357-366.
96. Yamashita T., Takahara T., Kwee T.C., et al. Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment. Jpn J Radiol 2011, 29(1):25-32.
97. Kwee T.C., Takahara T., Luijten P.R., et al. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010, 75(2):215-220.
98. He N., Xie C., Wei W., et al. Anew, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. Eur J Radiol 2012, 81(10):2602-2612.
99. Conlin JL, Rahbar H, Parsian S, etal. Quantitative MR characteristics of axillary lymph nodes to predict breast cancer metastatic involvement. Paper presented at: Proceedings of the Association of University Radiologists (AUR) Annual Meeting. Los Angeles, April 9-12, 2013.
100. Ma B., Meyer C.R., Pickles M.D., et al. Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment. Inf Process Med Imaging 2009, 21:276-287.
101. Olson ML, Rahbar H, Kurland BF, etal. Semi-automated method for improved reproducibility of apparent diffusion coefficient measurements in breast lesions. Paper presented at: International Society of Magnetic Resonance in Medicine (ISMRM) Annual Meeting. Salt Lake City, April 30, 2013.
102. Baltzer P.A., Schafer A., Dietzel M., et al. Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol 2011, 21(1):1-10.
103. Eyal E., Shapiro-Feinberg M., Furman-Haran E., et al. Parametric diffusion tensor imaging of the breast. Invest Radiol 2012, 47(5):284-291.
104. Partridge S.C., Ziadloo A., Murthy R., et al. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors. JMagn Reson Imaging 2010, 31(2):339-347.